MeSH D000312 - congenital adrenal hyperplasia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| A.H. Robins Company | Hydrocortisone | Hydrocortisone |  | 1982-01-01 |  |  |
| Abbott Biotherapeutics | Hydrocortisone | A-hydrocort |  | 1982-01-01 |  |  |
| Able Laboratories | Hydrocortisone | Hemsol-hc |  | 1992-06-19 |  |  |
| Allergan | Hydrocortisone | Aeroseb-hc |  | 1982-01-01 |  |  |
| Hydrocortisone | Penecort |  | 1984-06-06 |  |  | |
| Hydrocortisone | Acetasol |  | 1982-01-13 |  |  | |
| Hydrocortisone | Hydrocortisone |  | 1982-01-01 |  |  | |
| Hydrocortisone butyrate | Hydrocortisone Butyrate |  | 2017-12-08 |  |  | |
| Hydrocortisone, Neomycin, Polymyxin b | Otocort |  | 1982-01-01 |  |  | |
| Alpharma | Hydrocortisone | Hydrocortisone |  | 1982-06-07 |  |  |
| Altana | Hydrocortisone, Bacitracin, Neomycin, Polymyxin b | Bacitracin-neomycin-polymyxin W/ Hydrocortisone |  | 1982-01-01 |  |  |
| Hydrocortisone | Hydrocortisone |  | 1982-01-01 |  |  | |
| Amring Pharmaceuticals | Hydrocortisone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Hydrocortisone |  | 2005-10-31 |  |  |
| ANI Pharmaceuticals | Hydrocortisone | Cortenema |  | 1982-01-01 |  |  |
| Hydrocortisone probutate | Pandel |  | 1997-02-28 |  |  | |
| APP Pharmaceuticals | Hydrocortisone | Hydrocortisone |  | 1984-06-08 |  |  |
| Astex Pharmaceuticals | Hydrocortisone butyrate | Locoid |  | 1983-01-07 |  |  |
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
100%8/8
Phase 2
47%8/17
Phase 3
92%12/13
Approved: 6Overall Success rate: 43%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use